Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | DHODH | Q02127 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | CACNA1I | Q9P0X4 | 1/20 | 0.31 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29501742 | 1.00 | HTT (0.35) | HTTPOLBSLC6A2MAPTALDH1A1 | |
| SCHEMBL29047772 | 1.00 | HTT (0.35) | HTTPOLBSLC6A2MAPTALDH1A1 | |
| SCHEMBL29501778 | 0.86 | SLC6A3 (0.36) | HTTLMNASMN1; SMN2 | |
| SCHEMBL23680930 | 0.86 | SLC6A3 (0.36) | HTTLMNASMN1; SMN2 | |
| SCHEMBL23680931 | 0.81 | NR3C2 (0.34) | SLC6A2MAPT | |
| SCHEMBL23680918 | 0.81 | IDO1 (0.35) | HTTSLC6A2MAPTLMNATP53 | |
| SCHEMBL29501811 | 0.81 | NR3C2 (0.34) | SLC6A2MAPT | |
| SCHEMBL29501757 | 0.81 | IDO1 (0.35) | HTTSLC6A2MAPTLMNATP53 | |
| SCHEMBL20662030 | 0.77 | NR1H4 (0.36) | HTTMAPTALDH1A1LMNAGAA | |
| SCHEMBL20892686 | 0.76 | MEN1 (0.41) | HTTMAPTALDH1A1LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111344279-B | Microbiocidal picolinamide derivatives | 先正达参股股份有限公司 | 2023-07-07 | — | — | CN | disclosed |
| US-20210227826-A1 | Microbiocidal Picolinamide Derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2021-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210227826-A1 | Microbiocidal Picolinamide Derivatives | CASP2, CASP1, MSR1 | HTT 3499/4885POLB 2946/4885SLC6A2 3851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.